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Abstract
Background: Increasing numbers of individuals may be exposed to nanomaterials during pregnancy. The
overarching goal of this investigation was to determine if prenatal inhalation exposure to copper nanoparticles (Cu
NPs) has an effect on dams and offspring, including an analysis of inflammatory markers (Th1/Th2 cytokine profiles).
Methods: Physicochemical characterization of Cu NPs was performed. Pregnant and non-pregnant mice (C57Bl/6 J)
were exposed to Cu NPs or laboratory air in the whole-body chamber for 4 hrs/day on gestation days (GD) 3–19
(3.5 mg/m3). Animals were euthanized on GD 19 (0 week) or 7 weeks later. Bronchoalveolar lavage (BAL) fluid was
analyzed for total and differential cells. Cytokine/chemokine concentrations were determined in the BAL fluid and
the plasma of dams/non-pregnant mice and pups. Cu content was determined in the lungs and the blood of
dams/non-pregnant mice and pups, in the placentas as well as in the whole bodies of pups immediately after
delivery. Lungs and placentas were evaluated for histopathological changes. Gene expression of the Th1/Th2
profiles were analyzed in spleens of pups.
Results: The survival rate of 7 week old pups exposed to Cu NPs was significantly lower than control pups (73 vs. 97 %).
The average litter size, male/female ratio, body weight and lenght at birth were not different between Cu NP-exposed
and control mice. Both pregnant and non-pregnant mice exposed to Cu NPs had significant pulmonary inflammation
with increased number of neutrophils in the BAL fluid compared to controls. Perivascular lymphoplasmacytic cuffing was
found in the lungs of exposed mice and was more pronounced in the non-pregnant group. Similarly, levels of
inflammatory cytokines/chemokines IL-12(p40), G-CSF, GM-CSF, KC, MCP-1, MIP-1α, MIP-1β, RANTES and TNF-α in BAL
fluid were significantly higher in non-pregnant than pregnant exposed mice. Histopathology evaluation of placentas did
not identify any pathological changes. No translocation of Cu into the placenta or the fetus was found by inductively
coupled plasma-mass spectroscopy. Expression of several Th1/Th2 or other immune response genes in pups’ spleens
were found to be significantly up- or down-regulated.
Conclusions: Prenatal exposure to Cu NPs caused a profound pulmonary inflammation in dams and strong
immunomodulatory effects in offspring. There was no clear polarization of genes expressed in pups’ spleens towards
Th1 or Th2 type of response.
Keywords: Copper nanoparticles, Prenatal, Inhalation, Toxicity, Pregnancy, Mice, Th1/Th2 profiles, Immunotoxicity
* Correspondence: andrea-a-dodd@uiowa.edu
1Department of Occupational and Environmental Health, University of Iowa,
College of Public Health, UI Research Park, IREH 170, Iowa City, IA 52242, USA
Full list of author information is available at the end of the article
© 2015 Adamcakova-Dodd et al. Open Access This article is distributed under the terms of the Creative Commons Attribution
4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Adamcakova-Dodd et al. Particle and Fibre Toxicology  (2015) 12:30 
DOI 10.1186/s12989-015-0105-5
Background
Human exposure to ultrafine particles in ambient air has
been associated with adverse health outcomes including
pulmonary and cardiovascular diseases [1–3], lung cancer
[4], allergy and with adverse pregnancy outcomes such as
premature birth, reduced birth weight, small size for gesta-
tional age and still birth [5]. Animal studies demonstrate
that in utero exposure to fine and ultra-fine particles leads
to multiple deleterious immunological changes in offspring,
such an inhibition of Th1 maturation and postnatal asthma
development [6, 7]. It has been shown that in many cases
nanoparticles (NPs) are taken up by cells and induce pro-
duction of pro-inflammatory cytokines and can likely have
immunomodulatory effects on the exposed organism [8].
With the fast development of nanotechnology the po-
tential risks of NP exposure to human health is expanding.
A wide variety of consumer products already contain a
varying array of nanomaterials including health and fitness
products, targeting pharmaceuticals, cosmetics, antibac-
terial clothes, home and garden products, electronics and
computers, and paints. Therefore, chances for exposure to
engineered nanomaterials are increasing for the public as
well as for individuals in the occupational environment.
Inhalation is one potential route of exposure and can
occur during manufacturing, accidental release of mate-
rials, use of consumer products or medical applications.
Even though it is a small percentage of the population, the
most vulnerable and sensitive group to the adverse effects
of NP exposure are pregnant women and their developing
fetuses. However, there is limited information about the
effects of exposure to nanomaterials during pregnancy.
The risk of these materials is not only related to the man-
ufactured quantities and the probability of exposure but
also on the reactivity and potency to biological systems,
including the immune system [9]. Increased inflammation
during pregnancy (including production of a number of
pro-inflammatory cytokines) may negatively influence the
normal fetal development and may have negative postna-
tal consequences.
Copper and copper oxide nanoparticles have been used
and investigated for a large number of applications, such as
oxidation catalysts and as a component of solar cells [10],
as well as being the major element of conductive inks and
pastes used in inkjet-printed electronics [11]. Other appli-
cations are being developed due to their anti-microbial,
anti-biotic and anti-fungal properties when incorporated in
coatings, plastics and textiles and for biomedical applica-
tions [12, 13].
In the last several years, an increasing number of studies
have investigated the possibility of transport of nanoma-
terials via placenta [14–16] and their effect on the fetus
[17–22]. If NPs cross the placenta, they might result in a
direct effect on the fetus. Indeed an ex vivo study of bar-
rier capacity of human placenta found that polystyrene
particles (50, 80, 240, and 500 nm) were able to penetrate
the placental barrier [15]. Similarly, an in vivo study in
mice showed that quantum dots crossed the placental bar-
rier [17]. There might also be indirect effects of prenatal
inhalation exposure to NPs on the developing fetus. Up to
now, there are a limited numbers of studies that focused
their research on in utero effects of NPs after repeated
inhalation exposure [18, 19, 23]. These studies show that
even after inhalation exposure during gestation, NPs can
directly or indirectly affect offspring. Inhaled cadmium
oxide NPs negatively impacted fetal and neonatal develop-
ment and growth [18]. Inhalation of nano-sized coated
TiO2 during gestation caused lung inflammation in adult
mice and neurobehavioral changes in offspring [19]. In
utero pulmonary exposure to carbon black induced liver
DNA damage in dams and offspring [23]. Furthermore, as
it was addressed recently by Hougaard et al. [24], there is
a lot of uncertainties about embryo-fetal development and
health later in life after inhalation exposure to NPs and
more studies in this area are warranted.
Normal pregnancy is a complex immunological state.
There is a shift from Th1 to Th2 responses that function-
ally induces maternal tolerance and immunosuppression
and protects the fetus [25]. Since nanomaterials have vary-
ing biological properties, each NP can cause disparate
modulation of the immune system. For example, two cata-
lytically different metallic NPs have shown nearly opposite
effects on Th1/Th2 polarization. While titanium di-
oxide (TiO2) NPs potentiated polarization towards
Th1-responses, cerium oxide (CeO2) induced Th2-
dominated responses [8].
The objective of this study was to assess the effects of
inhalation exposure to Cu NPs on dams and offspring in
utero using a murine pregnancy model. Based on previous
studies investigating Cu NPs [26, 27], we expected robust
inflammatory responses in particle-exposed mothers. We
sought to determine if prenatal exposure to inhaled Cu
NPs had an effect on 1) basic gestational and developmen-
tal parameters, 2) immune/inflammatory responses in the
mother during pregnancy compared to non-pregnant mice,
3) translocation of Cu NPs through placental barrier into
the fetus, 4) basic pathology of placenta, and 5) immune
responses in offspring (expression of Th1/Th2 and other
immune response genes in spleens).
Results
The experimental design, exposure timeline as well as
number of animals per each time point shown in Fig. 1
highlights evaluation of dams, non-pregnant mice and
pups immediately after prenatal exposure to Cu NPs and
50 days later when adolescent pups were evaluated. There
were 4 experimental groups: pregnant exposed, pregnant
control, non-pregnant exposed and non-pregnant control
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group. Non-pregnant mice received the same exposure
and were necropsied at the same time as pregnant groups.
Physicochemical characterization of NPs
The size of the Cu NPs evaluated by TEM (Fig. 2a, b)
showed an average primary particle size of 15.7 ± 9.6 nm
(smaller than the manufacturer’s stated size of 25 nm).
The surface area of primary particles measured by BET
analyses was 14.6 ± 0.5 m2/g (Table 1). Powder XRD of
the nanomaterial characterized immediately after open-
ing the sealed package containing the nanoparticles
showed the presence of metallic Cu along with the pres-
ence of Cu2O (cuprite). During handling the nanomater-
ial for aerosol generation and during storage, Cu NPs
powder was exposed to the ambient environment. XRD
analyses of these particles showed they aged and further
oxidized leading to the presence of two phases: the me-
tallic copper phase and a more oxidized coating of CuO
(tenorite) on the surface of the particle. The average
mobility diameter of airborne particles in the exposure
chamber was 35.6 nm with GSD = 1.7 nm (Table 1,
Fig. 2c).
Gestational parameters
During the time of exposure, pregnant exposed mice
gained significantly less weight than pregnant controls
(p < 0.05, ANOVA for repeated measures). In non-
pregnant groups, there was no statistical difference in
weight gain (Fig. 3a). Both male and female pups with
prenatal exposure to Cu NPs gained significantly less
weight during postnatal days than their control counter-
parts (Fig. 3b). Survival rate of pups was significantly
(p < 0.001) lower in exposed mice than controls (Fig. 3c,
Table 2). Only 73 % of pups with prenatal exposure to
Cu NPs survived up to 50 PNDs compared to 97 % of
controls. All of the pups that died were lost in the first
2 weeks (wks) after delivery, with 16 % loss at 1 week
(wk) and 27 % loss at 2 wks after delivery. The length of
Fig. 1 The experimental study design and the number of animals per each evaluated endpoint. All mice (dams and non-pregnant mice) were exposed
to Cu NPs or filtered laboratory air (4 hrs/day) from gestation day (GD) 3 to 19. A selected number of mice was euthanized on GD 19 and the pups were
delivered by Caesarian section (0 wk post exposure). Another group of mice delivered the pups spontaneously on GD 18–20, these pups grew until adoles-
cence when they were euthanized at 50 postnatal days (PND). # There were 4 mice in the pregnant group exposed to Cu NPs, all other experimental
groups had 5 animals
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gestation as well as average litter size was slightly lower in
exposed mice than controls, but not significantly. There
were no other significant differences between exposed and
control mice in the following parameters (Table 2): gesta-
tion length, average litter size, male/female ratio, birth
weight, and birth body length. Each dam delivered be-
tween 6–9 pups with an average litter size of 6.2 ± 1.1 in
exposed group and 7.1 ± 2.7 in control group (means ±
standard deviations).
Evaluation of BAL fluid cells
Pregnant and non-pregnant mice
The total number of white blood cells recovered by BAL at
0 wk after exposure was significantly higher in Cu-NP-
exposed pregnant (5710 ± 1550 × 103 cells per mouse) or
non-pregnant mice (5840 ± 720 × 103 cells per mouse)
compared to their sham counterparts (p < 0.05 and p <
0.001, respectively, Fig. 4a). This major increase was 53-fold
in pregnant and 81-fold in non-pregnant Cu-NP-exposed
mice compared to their controls. The number of cells
decreased 7 wks after the exposure, but there was still a
significant 8-fold (p < 0.001) and 6-fold (p < 0.01) increase
in exposed pregnant and non-pregnant mice, respectively
compared to their controls. There was no significant
change in recruitment of total cells into the lungs between
exposed pregnant and non-pregnant mice. The number of
macrophages in BAL fluid showed a similar trend as the
total number of cells, with the highest recruitment in non-
pregnant Cu-NP-exposed mice at 0 wk post exposure
(3314 ± 538 × 103 cells per mouse), followed by pregnant
Cu-NP-exposed group (3083 ± 937 × 103 cells per mouse)
at 0 wk post exposure. The number of macrophages was
significantly higher in both exposed groups compared to
shams (Fig. 4b).
Recruitment of neutrophils into the airways immedi-
ately after the last exposure was also significantly
increased in both pregnant (2320 ± 820 × 103 cells per
mouse, p < 0.05) and non-pregnant (1850 ± 670 × 103
cells per mouse, p < 0.01) exposed groups compared to
their pregnant and non-pregnant controls (0.5 ± 0.2 and
0.4 ± 0.2, respectively). At 7 wks post exposure, the num-
ber of neutrophils was found to be similar to controls
(Fig. 4c). The number of lymphocytes in BAL fluid per
mouse at 0 wk after exposure was significantly (p < 0.05)
increased (Fig. 4d) in exposed pregnant (304 ± 114 ×
103) and non-pregnant mice (681 ± 180 × 103) compared
to pregnant and non-pregnant controls (0.9 ± 0.4 × 103
and 1 ± 0.1 × 103, respectively). No eosinophils were
found in BAL fluid.
Pups
Spontaneously delivered pups were necropsied at 50 PND.
The total number of cells in BAL fluid was increased in
pups with prenatal exposure to Cu NPs (293 ± 66 × 103
cells per mouse) compared to controls (155 ± 23 × 103 cells
per mouse), but this increase was not significant (p < 0.06).
The number of macrophages was significantly (p < 0.02)
increased in prenatally exposed pups (223 ± 36 × 103 cells
per mouse), compared to controls (152 ± 22 × 103 cells per
mouse) while the number of neutrophils and lymphocytes
in BAL fluid did not differ from controls (Fig. 5). No eosin-
ophils were found in BAL fluid.
Table 1 Physicochemical characterization of Cu NPs
Particle characteristic Cu NPs
Primary particle diameter 15.7 ± 9.6 nm
BET surface area 14.6 ± 0.5 m2/g
Particle size in the exposure chamber GM = 35.6 nm
GSD = 1.7 nm
Exposure aerosol concentration 3.5 ± 1.2 mg/m3
A B C
Fig. 2 Characterization of Cu NPs. Particle size distribution of primary Cu NPs (a) TEM image of primary Cu NPs (b), and the size distribution of
generated Cu NP aerosol in the whole-body exposure chamber (c)
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Cytokines in BAL fluid and plasma
An array-based analysis panel of 23 cytokines/chemokines
was used to analyze supernatants of BAL fluid from dams/
non-pregnant mice at 0 day post exposure and pups at 50
PNDs. Of the proteins tested from BALs, some cytokines
were below lowest limit of detection: IL-1α, IL-2, IL-3, IL-4,
IL-5 and IL-12(p70). The concentration of IL-10 was very
low in non-pregnant groups and not detected in pregnant
mice. Cytokines that were detectable in adult females’ BAL
fluid were higher in both exposed groups of mice (pregnant
and non-pregnant) compared to controls. The concentra-
tions of the following cytokines were significantly higher in
exposed non-pregnant mice compared to exposed pregnant
mice: IL-1β, TNF-α, and IL-6 (in Th1 group, Fig. 6a),
RANTES, G-CSF and GM-CSF (in Th2 group, Fig. 6b),
MCP-1, MIP-1α, MIP-1β and KC (in other cytokines/
chemokine group, Fig. 6c). The highest chemokine level
in BAL fluid among Cu-NP-exposed mice was MCP-1,
with a 4-fold higher concentration in non-pregnant mice
(7930 ± 1880 pg/mL) compared to pregnant mice (1710 ±
700 pg/mL). The second highest concentration was IL-
12(p40) with a 4-fold higher concentration in exposed non-
pregnant mice (940 ± 100 pg/mL ) compared to exposed
pregnant mice (220 ± 40 pg/mL). For the pups, the majority
of the cytokines/chemokines were not detected with the ex-
ception of IL-9, IL-12(p40), IL-13, IL-17, IFN-γ, KC, and
TNF-α. However there were no significant concentration
differences in pups with prenatal Cu-NP-exposure vs. con-
trols (data not shown).
The same array of cytokines/chemokines was analyzed in
the plasma of dams/non-pregnant mice and pups. Cyto-
kines that were significantly elevated in the plasma of non-
pregnant exposed mice compared to non-pregnant controls
as well as compared to pregnant mice exposed to Cu NPs
included: IL-12(p40), IL-6, and G-CSF (Fig. 6d and e). The
concentrations of cytokines/chemokines in the plasma of
pups were very low and there were no significant differ-
ences between exposed and control pups (data not shown).
Histopathology of lungs and placenta
Lung tissue evaluations of controls and exposed dams/
non-pregnant mice showed a negative effect of NP inhal-
ation in all exposed groups compared to controls. The
pathology findings were minor but more pronounced in
non-pregnant mice as opposed to the pregnant group
(Fig. 7 and Table 3). There were varying amounts of
amorphous alveolar debris and foamy alveolar macro-
phages in the lungs of exposed mice, both pregnant and
non-pregnant. Neutrophilic alveolar inflammation, repre-
sented by multifocal pockets of neutrophils within the
lungs, was only found in non-pregnant exposed mice at
day 0. Similarly, perivascular lymphoplasmacytic cuffing
was most distinct in the non-pregnant day 0 group, but
was also present in both exposed groups at day 50 post ex-
posure. Cuffing at day 50 was less prominent than at
0 day post exposure and was more multifocal. There were
no notable pathology findings in either the lungs from the
pups or the placentas in either the sham or the exposed
Fig. 3 Body weights of all animals and survival rate of pups. The body weights of pregnant and non-pregnant mice during Cu NPs exposure (a). Postnatal
body weights of pups (b) and postnatal survival rate of pups after prenatal inhalation exposure to Cu NPs (c). Significant value **p< 0.1 in a represents the
comparison between pregnant exposed vs. pregnant controls. Significant value ***p< 0.001 in b represents the comparison between exposed males vs.
control males and exposed females vs. control females pups
Table 2 Gestational parameters




Male/female (ratio) Birth weight ± SE, g Body length at
birth ± SE, mm
Survival rate at
50 PNDs
Exposure 18.4 ± 0.6 6.2 ± 1.1 14/13 (1.08) 1.22 ± 0.01 25.00 ± 0.16 73 %***
Controls 19.0 ± 0.0 7.1 ± 2.7 29/26 (1.12) 1.28 ± 0.01 24.93 ± 0.13 97 %
SD standard deviation
PND - postnatal days
***p < 0.001 significantly lower survival rate compared to controls
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groups. The morphology of major vessels and capillaries
in placenta were evaluated as well as the labyrinth, decid-
ual and spongiotrophoblast layers were measured in all
placental tissues and no significant differences were noted
(Additional file 1).
Determination of Cu levels
Cu was measured by ICP-MS in the whole blood and in
the lungs of pregnant and non-pregnant mice, placentas,
fetuses delivered by Caesarian section (C-section) at GD
19, and pups (whole blood) at 50 PND (Table 4). There
was no significant difference in Cu concentration in the
whole blood between exposed dams and controls. Both
groups of pregnant mice, exposed as well as shams, had a
2-fold increase in Cu levels in the whole blood, compared
to non-pregnant mice. Interestingly, the inhalation of Cu
NPs did not elevate Cu concentrations in the blood of
exposed animals. The levels of Cu in the lung tissue of
exposed pregnant mice (85.9 ± 3.9 μg/L) at 0 PND were
increased significantly (p < 0.001) compared to pregnant
shams (23.4 ± 4.1). Also highly significant elevation (p <
0.0001) of Cu levels in the lungs was found in non-
pregnant exposed (54.4 ± 2.8 μg/L) mice compared to
non-pregnant shams (13.0 ± 1.2 μg/L). The levels of Cu in
lung tissue of exposed pregnant and non-pregnant mice
were 3.7- and 4.2-times higher, respectively, compared to
Fig. 4 Cell numbers in BAL fluid of exposed and control pregnant and non-pregnant mice. A comparison of the number of total cells (a), macrophages
(b), neutrophils (c) and lymphocytes (d) in the BAL fluid in pregnant and non-pregnant mice exposed to Cu NPs and their sham counterparts. c the
percentage of neutrophils out of the total number of cells is also shown. Values are expressed as mean ± SE. Statistically significant differences between
exposed groups and control counterparts (shams) are indicated as follows: *p< 0.05, **p< 0.01 and ***p< 0.001
Fig. 5 Cell numbers in BAL fluid of exposed and control pups. The
total cell number and number of macrophages, neutrophils and
lymphocytes in the BAL fluid of mice at 50 PNDs that were exposed
to Cu NPs during gestation days 3–19. Values are expressed as
mean ± SE. Statistically significant difference between the exposed
group and the control group is indicated as *p < 0.05
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Fig. 6 Cytokine/chemokine concentrations. The concentration of cytokines/chemokines in the BAL fluid (a-c) and the plasma (d-f) of pregnant and
non-pregnant mice exposed to Cu NPs during gestation and their control counterparts divided into functional groups as follows: Th1 cytokines (a and
d), Th2 cytokines (b and e) and other cytokines/chemokines (c and f). Values are expressed as mean ± SE. Statistically significant differences between
the exposed groups and the control counterparts (shams) are indicated as follows: *p < 0.05, **p < 0.01 and ***p < 0.001
Fig. 7 Lung histopathology. Lung from mice exposed to Cu NPs and euthanized immediately after C-section on GD 19 (0 PND) exhibited histopathologic
changes including mild to moderate, multifocal inflammatory cell infiltration within the interstitium which is composed primarily of lymphocytes and
neutrophils with fewer plasma cells and macrophages (thick arrows). Also present was multifocal accumulations of a basophilic, flocculent, amorphous
material (thin arrows). The pathology findings were more pronounced in non-pregnant mice as opposed to the pregnant group. There were no pathologic
findings in control mice. Bars = 200 μm (inset, bars = 20 μm)
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controls. Cu concentrations in the blood as well as in lungs
were found to be lower at 50 PND compared to 0 PND,
but there was still 2.2- and 1.7- times increase in exposed
pregnant and non-pregnant mice, respectively, compared
to controls.
There was no significant difference in Cu levels in placen-
tas (19.9 ± 1.8 mg/kg vs. 17.6 ± 1.6 mg/kg), fetuses (whole
body) at GD 19 (11.6 ± 0.3 mg/kg vs. 11.1 ± 0.5 mg/kg) or
in the whole blood of pups at 50 PND (600 ± 18.9, μg/L vs.
655 ± 30.0, μg/L) between exposed group and controls,
respectively.
Gene expression analyses
The mRNA expression of 84 genes involved in T-helper cell
(Th cell) immune responses was determined in spleenic
mRNAs of pups at 50 PNDs with prenatal exposure to Cu
NPs and compared to control pup spleenic mRNA. Out of
84 genes, 14 genes were significantly (p < 0.05) up-regulated
at least 2-fold from controls and 11 genes were signifi-
cantly (p < 0.05) down-regulated at least 2-fold from con-
trols (Fig. 8). The two highest up-regulated genes were
Lta (Lymphotoxin A, 6-fold) and Gfi1 (Growth factor
independent 1, 5-fold). The most significantly down-
regulated genes were Sftpd (Surfactant associated protein
D, 630-fold, Spp1 (Secreted phosphoprotein 1, 27-fold),
Csf2 (Colony stimulating factor 2 [granulocyte-macro-
phage], GM-CSF, 9-fold), Ccl11 (Chemokine (C-C motif)
ligand 11, eotaxin, eosinophil chemokine, 7-fold), and
Tgfb3 (Transforming growth factor, β 3, 7-fold). There
was no clear polarization towards Th1- or Th2-related
genes. Table 5 lists only genes with fold-change > = 2 or p-
value < 0.1.
Discussion
Regardless of the numerous benefits of nanotechnology
applications, there is a potential health threat from nano-
particle exposure that needs to be addressed also in more
susceptible populations, including pregnant women and
developing fetuses. Exposure to NPs during sensitive
developmental stages of life may predispose an organism
to diseases later in life. In our study, we assessed the
effects of prenatal inhalation of Cu NPs on dams and
offspring using a mouse model.
Table 3 Histopathology scores of exposed and control pregnant and non-pregnant groups immediately after delivery on GD 19
(PND 0) and 50 days later (PND 50)
Experimental Group Number of mice
per group
Histopathology Scorea
Alveolar macrophages Alveolar debris Perivascular cuffingb
Exposed Pregnant, PND 0 n = 4 1 2 0.75
Non-Pregnant, PND 0 n = 5 1 1 1.8
Pregnant, PND 50 n = 5 1 0 0.2
Non-Pregnant, PND 50 n = 5 0.6 0 0.2
Shams Pregnant, PND 0 n = 4c 0 0 0
Non-Pregnant, PND 0 n = 4c 0 0 0
PND postnatal day
aScoring system: 0 = none, 1 = few/rare, 2 = multifocal/moderate, 3 = many/coalescing and/or diffuse
bLymphocytes and plasma cells surrounding blood vessels
cOnly 4 mice out of 5 were evaluated for pathology changes in control groups
Table 4 Dosimetry of Cu NPs in the whole blood, lung and placenta
Experimental group Cu Concentration, Mean ± SE
Whole blood, μg/L Lungs, mg/kg Placenta, mg/kg Fetus (GD19), mg/kg
Adult females PND 0 PND 50 PND 0 PND 50
Exposed Pregnant 1400 ± 91.7### 644 ± 7.0 85.9 ± 3.9***, ### 28.5 ± 3.4**, ## 19.9 ± 1.8 11.6 ± 0.3
Non-Pregnant 737 ± 26.4 669 ± 20.7 54.4 ± 2.8*** 20.0 ± 0.6*** – –
Shams Pregnant 1450 ± 18.3 ND 23.4 ± 4.1 12.8 ± 1.0 17.6 ± 1.6 11.1 ± 0.5
Non-Pregnant 704 ± 13.2 ND 13.0 ± 1.2 11.8 ± 0.4 – –
Pups
Exposed – 600 ± 18.9 ND ND
Shams – 655 ± 30.0 ND ND
ND not determined
###p < 0.001, ##p < 0.01 significant difference between pregnant and non-pregnant mice
***p < 0.001, **p < 0.01 significant difference between exposed and control counterparts
Adamcakova-Dodd et al. Particle and Fibre Toxicology  (2015) 12:30 Page 9 of 18
We performed physicochemical characterization of com-
mercially available Cu NPs immediately after opening the
package prior to exposure to the ambient environment, as
well as after exposure that occurred during storage and
handling. The primary particle size evaluated by TEM was
15.7 ± 9.6 nm. As expected and observed previously, Cu
NPs can readily oxidize upon exposure to the ambient
environment and this can change the properties of the
original nanoparticles. The dynamic nature of Cu NPs is
described in Mudunkotuwa et al. [28]. Oxidation of Cu
NPs was also observed in our study during storage and
handling. Initial characterization of Cu NPs minimally
exposed to the ambient air showed the presence of mainly
metallic Cu with a thin coating of Cu2O (cuprite) on the
particle surface as shown by XPS. The XRD pattern of
material exposed to the ambient environment showed the
presence of two phases: metallic Cu and CuO (tenorite)
only with no Cu2O phase. An average mobility diameter of
airborne particles in the whole-body chamber was 35.6 nm
with GSD= 1.7 nm.
At present, there is not enough information available to
determine a potential hazard of prenatal exposure to NPs
especially by inhalation. Furthermore, the exposure limits
are nowadays available only for a limited number of nano-
materials (such as TiO2 and carbon nanotubes). Since there
are currently no exposure limits for Cu NPs, we based our
animal exposure studies on the current exposure limits for
coarse copper material. The Recommended Exposure Limit
(REL) for copper dust and mist (not including fumes)
established by the National Institute for Occupational
Safety and Health (NIOSH) as well as Permissible Exposure
Limit (PEL) by the Occupational Safety and Health Admin-
istration (OSHA) is 1 mg/m3 as a time-weighted average
concentration. The estimated dose of Cu NPs in the tra-
cheobronchial and pulmonary region after exposure during
gestation was 141 μg/mouse (6.1 mg/kg). This estimated
dose corresponded to the lung dose accumulated by a
human (70 kg) exposed to a concentration of 1 mg/m3 for
a period of 39.7 work wks (assuming breathing frequency
of 15 breaths/min, 600 mL/breath, and pulmonary depos-
ition fraction for 36 nm particles of 0.5) [29]. The average
length of a human pregnancy is 40 wks.
Basic gestational and developmental parameters were
affected by prenatal Cu NP exposure
Prenatal inhalation exposure to Cu NPs during GD 3 – 19
had a significant effect on some basic developmental and
gestational parameters. Maternal weight gain during gesta-
tion was lower in exposed pregnant mice than in controls.
Similarly, pups with prenatal exposure gained weight
slower than the control pups. Length of gestation, as well
as litter size were also slightly (not significantly) affected
by the exposure; all other basic gestational measures were
not affected. It is possible that with the increased sample
size per each group, these observations could become
significant. The survival rate of pups at 50 PNDs was
significantly lower in exposed mice than controls. Another
study investigating prenatal inhalation exposure of TiO2
particles (rutile) on GD 8–18, 1 hr/day, concentration of
42 mg/m3, found no effects on maternal weight gain,
length of gestation, loss of implantations, litter size,
offspring body weight or sex ratio. Pup survival during the
lactation period was not significantly reduced in TiO2
litters [19]. Intra-tracheal exposure to carbon nanoparti-
cles on GDs 7 – 14 (200 μg/mouse per each day) did not
affect basic gestational parameters [30]. This suggests that
Cu NPs have greater toxicity for fetuses than some other
nanomaterials. The observed lower survival rate of pups
with prenatal exposure to Cu NPs could potentially be due
to reduced food intake by exposed dams caused by inflam-
mation, secondary exposure to Cu NPs or Cu ions via lac-
tation, or disruption/alteration of immune, inflammatory,
Fig. 8 Spleenic gene expression in pups. The mouse Th1 and Th2 responses were identified in RNAs isolated from the spleens of pups after
prenatal exposure to Cu NPs by RT2 Profiler PCR Array (PAMM-034ZA, SABiosciences, Qiagen). Out of 84 genes, 14 genes were significantly
(p < 0.05) up-regulated at least 2-fold and 11 genes were significantly (p < 0.05) down-regulated at least 2-fold from the controls
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Table 5 Gene expression changes in Cu NP-exposed and control pups, spleen tissue (rtPCR array)
Out of all 84 genes, only genes with fold-change > = 2 are listed in this table. Genes are color-coded according to a response, red: Th1 related genes, blue: Th2
related genes, green: Th1 and Th2 responses, black: other genes involved in immune response
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metabolic, biochemical or endocrine pathways in offspring.
However, our study only explored inflammation and im-
mune pathways and does not offer an explanation for this
adverse effect.
Cu NP exposure during gestation affected immune/
inflammatory responses in mothers
We found significantly higher inflammatory responses in
the lungs of both pregnant and non-pregnant mice ex-
posed to Cu NPs during GD 3 – 19 compared to pregnant
and non-pregnant shams. This was represented by signifi-
cantly higher numbers of total leukocytes and neutrophils
in the BAL fluid. Production of Th1, Th2 or other cyto-
kines/chemokines in BAL fluid was significantly higher in
the non-pregnant group exposed to Cu NPs than in the
exposed pregnant group. Exposed non-pregnant mice had
also a higher systemic inflammation than pregnant ex-
posed mice. Our data suggest that the Th2 pregnancy en-
vironment partially protected the lungs of the pregnant
mice from the pro-Th1 effects of the Cu NPs. The histo-
pathology score of perivascular cuffing (represented by
lymphocytes and plasma cells surrounding blood vessels)
in nanoparticle-exposed mice was also 2.4-fold higher in
non-pregnant (1.8) than pregnant mice (0.75). We did not
observe a clear polarization of Th1 or Th2 cytokines in
BAL fluid of dams exposed to Cu NPs during gestation.
Several animal studies have reported on differences in
pulmonary inflammatory responses among pregnant and
non-pregnant rodents. Contrary to our study presented
here, several previous studies found pregnant rodents to
be more susceptible to various inflammatory stimuli than
non-pregnant animals. For example, pregnant rats had an
enhanced inflammatory response to inhaled endotoxin
[31] or acute ozone exposure [32] when compared to
non-pregnant controls. Similarly, much stronger pulmon-
ary inflammation was observed in pregnant mice than in
non-pregnant females after intra-nasal instillation of TiO2
or diesel exhaust particles [7]. The enhanced inflammation
in pregnancy after TiO2 particle exposure was recently
associated with impaired uptake of particles by macro-
phages due to estradiol release during pregnancy [33].
Based on our previous results [26, 27], we expected that
Cu NP inhalation exposure would cause an immense
inflammatory response; however, we wondered whether
the pregnancy phenotype (characterized by predominant
Th2 response) would have an effect on this inflammatory
response in pregnant vs. non-pregnant mice. Furthermore,
we sought to explore if enhanced inflammation during
pregnancy would modulate the immune system of the de-
veloping fetus. The immunomodulatory effects of various
nanomaterials have been reported previously, e.g. mater-
nal exposure to combustion-generated ultrafine particles
inhibited pulmonary Th1 maturation and enhanced
asthma development in offspring [6]. Indeed, we observed
a significant inflammatory response in the lungs of
exposed animals. However, this response was larger in the
non-pregnant mice than in their pregnant counterparts.
This finding might be explained by the fact that pregnancy
dominated with Th2 response is a state of maternal sup-
pression with anti-inflammatory effects, and thus, the
competition between anti-inflammatory effects of preg-
nancy and inflammatory effects of Cu NPs may have
occurred. Suppression of allergic pulmonary inflammation
was also found in asthmatic mice that were exposed to
fine or nanosized TiO2 particles suggesting that the
immunological status of the exposed mice determines the
modulation of the airway inflammation [34]. To offer
more definite explanations for these findings, studies with
different types of nanomaterials with various physico-
chemical properties and further evaluation of inflamma-
tion and endocrine pathways are warranted. Recently, a
study by Jones et al. [35] suggested that Th1-Th2 balance
is an important factor in NP clearance, the authors dem-
onstrated an increased clearance of NPs in Th2-prone
mice. However, clearance of particles is also dependent on
the physicochemical properties of nanomaterials as men-
tioned earlier. Furthermore, in our study there was a
physiological increase of Cu levels during pregnancy and
thus, assessment of the clearance of particles in our study
is more complex. We could not determine how much of
the increased Cu levels was due to a physiological increase
during pregnancy and how much was due to exposure to
Cu NPs.
No translocation of Cu ions into the placenta or fetus was
observed by ICP-MS
Nanoparticle translocation from the lung into circulation
and secondary target organs after inhalation exposure has
been previously reported [36, 37] and is very much
dependent on the particle size, surface area, charge, and
functionality, as well as solubility. The translocation of NPs
to fetus has been reported as very low and mainly occurring
after intravenous exposure [38–40]. Cu NPs were shown to
be highly soluble in artificial lung fluid [26]. Thus, we
hypothesized that translocation of Cu NPs into the blood
stream and possibly to the fetus was more probable than in
studies with non-soluble particles. However, our study did
not find any increased Cu levels in the placentas or fetuses.
Similarly, we did not observe translocation of Cu NP to
other tissues in our previous sub-acute inhalation study
[27]. The levels of Cu ions in the blood of exposed dams
were not significantly higher than in their control counter-
parts. Pregnancy itself increased the levels of Cu ions in the
blood, irrespective of the Cu NP exposure. On the other
hand, some of the nanoparticles were likely cleared from
the lungs by the mucociliary escalator to the trachea and
digestive system or lymphatic system, but this was not
determined in this study.
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Our result of increased Cu levels in blood during preg-
nancy is in an agreement with the results of existing human
studies [41–44]. Many of them report a 2-fold increase of
Cu levels in blood at full term, as was also seen in our
study. The increase of Cu levels in lungs of exposed mice
was approximately 4-fold, in both pregnant and non-
pregnant mice. The levels of Cu in other organs were not
determined in this study. It is possible that only a very small
percentage of delivered material (in the particle form or in
the form of Cu ions after potential dissolution) translocated
into the blood and other target organs as was reported in
other studies [38, 45, 46] and we were unable to detect the
Cu using the ICP-MS method, which was a limitation of
this study. Interestingly, we saw retention of Cu in the lungs
7 wks after exposure; there was still 34 and 37 % retained
Cu from the original amount found in the lung at the end
of gestation in pregnant and non-pregnant exposed groups,
respectively.
No histopathological changes in the placental tissues
were found
Inhalation of particles during pregnancy may induce acute
placental inflammation [47] that can lead to inadequate pla-
cental perfusion and decrease transplacental nutrient ex-
change [48]. Several studies found that inhaled or injected
NPs enter the circulatory system and can migrate to various
organs or tissues [49, 50]. Particles containing lead and
nickel were found in human placentas from subjects living
in proximity to polluted areas [51]. The accumulation of
environmental pollutants in the placenta may cause hypoxia
that can result in enzymatic changes. The increased activity
of lactate dehydrogenase (LDH) was found in human pla-
centas from women residing in areas polluted with fine
metal particles [52]. The pollutants captured in the placen-
tal tissue may diminish placental function via impairment
of placental microstructure [53]. Thus, even if the direct
translocation of NPs from mother to fetus would not occur,
NPs that are taken up by the placenta may cause placental
functional changes and subsequently have an impact on the
developing fetus. Damaging effects observed in fetuses after
i.v. administration of silica NPs were linked to structural
and functional changes in the placenta only at the highest
concentration of 0.8 mg per mouse [39]. Inhalation of diesel
exhaust caused immunological changes in the placentas of
exposed mice [54]. Our study did not find any histopatho-
logical changes in the placental tissues (Additional file 1).
Functional changes of the placentas potentially caused by
Cu NP exposure were not evaluated in this study, but since
we found a significantly lower survival rate of pups that
were prenatally exposed to Cu NPs, as well as changes in
immunological responses of exposed mothers, functional
changes are not excluded and should be investigated
further.
Prenatal inhalation exposure to Cu NPs induced gene
expression changes in Th1/Th2 or other immune
responses in spleenic mRNAs in offspring
In utero exposure to xenobiotics has been proposed as
an important driver for gene reprogramming that may lead
to the development of higher vulnerability or resistance to
various diseases. The spleen is the largest lymphatic organ
and is the primary site of innate and adaptive immune
processes, and along with the bone marrow, it is the main
organ involved in the manufacturing, maturation, differen-
tiation, proliferation and storage of immune cells.
Of 84 genes involved in T helper cell (Th cell) immune
responses that were determined in spleenic RNAs of pups
at 50 PNDs with prenatal exposure to Cu NPs, a number
stood out as having potential health links. For one, mRNA
encoding Surfactant associated protein D (Sftpd) was found
to be the most down-regulated (633-fold) compared to con-
trols (p < 0.04). Surfactant protein (SP)-D plays an import-
ant role in pulmonary innate immunity. But it is also
known to be involved in non-pulmonary modulation of
inflammation [55]. The presence of SP-D in extrapulmon-
ary tissues has been reported in various mammals [56]. As
reviewed by others [57, 58] SP-D mediates many mecha-
nisms such as opsonization of pathogens, activation of
phagocytosis and modulation of toll-like receptor (TLR)
activity. It was also suggested that surfactant proteins, both
SP-A and SP-D, can modulate the immune response to
allergens and/or development of allergic reactions [59]. A
protective role of SP-D in the pathogenesis of allergic
airway disease was found (a study using wild type or
SP-D−/− mouse model challenged with house dust mite
antigen) [60]. Many other immune roles pulmonary and
extrapulmonary are reviewed by Nayak et al. [61].
Another gene that was found to be significantly (p < 0.01)
down-regulated (27-fold) in prenatally exposed pups was
Secreted phosphoprotein 1 (Spp1; also known as Osteopon-
tin). Spp1 was found to modulate immune responses at
several levels: recruits cells to sites of inflammation, assists
in cell attachment and wound healing, mediates cell activa-
tion and cytokine production through interaction with
cellular signaling pathways, and it is involved in specific
apoptosis pathways. During inflammation it stimulates both
pro- and anti-inflammatory processes. Deficiency of this
protein is connected to reduced Th1 immune responses in
infectious diseases, autoimmunity and delayed type of
hypersensitivity [62].
Granulocyte/macrophage colony-stimulating factor (GM-
CSF; also known as Csf2) stimulates proliferation, activa-
tion, and differentiation of macrophages, granulocytes,
neutrophils, eosinophils, and monocytes [63]. The gene of
this protein was also found to be significantly (p < 0.05)
down-regulated (9-fold) in the pups’ spleens.
The three most up-regulated genes in the pups’ spleens
were Lymphotoxin-α (Lt-α, also known as tumor necrosis
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factor-β, [TNF-β]) 6-fold (p < 0.05), Gfi1 (Growth factor in-
dependent 1) 5-fold (p < 0.02), and IL-10 (4-fold, p < 0.005).
Lt-α is a cytokine produced by lymphocytes and a mem-
ber of the TNF family. It is essential in the organogenesis of
secondary lymphoid organs (spleen, lymph nodes, and
Peyer’s patches) and may induce the development of ter-
tiary lymphoid tissue (accumulation of lymphoid cells in
chronic inflammation). Other genes related to the TNF
family (ligands or receptors) were also up-regulated, some
significantly so, such as Tnf 2.6-fold (p < 0.04), Cd40lg
(CD40 ligand, TNFSF5) 3-fold (p < 0.03) and Tnfrsf8 (Tnf
receptor superfamily, member 8, 1.6-fold, p < 0.03) and
Tnfsf4 (Tnf (ligand) superfamily, member 4) was up-
regulated (2-fold) but not significantly (p < 0.09).
Gfi1 (Growth factor independent 1) is a transcriptional
repressor that is induced during T-cell differentiation
and plays a critical role in enhancing Th2 cell expansion
by promoting proliferation and preventing apoptosis. It
has been suggested that it works synergistically with
Gata3 and provides a mechanism through which IL-4
could promote Th2 cell expansion [64].
The third most up-regulated gene was IL-10, which is
known to inhibit inflammatory pathologies and functions
at different phases of immune responses and potentially at
different anatomical locations. IL-10 was originally recog-
nized as a Th2-type cytokine, but later evidence suggested
that it is more relevant to regulatory T (TReg) cell
responses and now it is considered a much more broadly
expressed cytokine. IL-10 is expressed by many adaptive
immune cells including Th1, Th2, and Th17 cell subsets,
TReg cells, CD8+ T cells and B cells [65]. Due to the fact
that various cell types can express IL-10 the regulation of
this cytokine is quite challenging. In our study it appears
that more pro-inflammatory cytokines were expressed in
pups. However, the pathways that induce IL-10 expression
may also negatively regulate the expression of these pro-
inflammatory cytokines. In many cases, IL-10 is induced
together with pro-inflammatory cytokines [65].
Conclusions
Prenatal exposure to Cu NPs caused a profound pulmonary
inflammation in dams with negative effect on pups’ survival
after delivery. Many up- and down-regulated genes related
to Th1/Th2 type responses point to immunomodulatory
effects of Cu NPs in offspring after prenatal inhalation ex-
posure. Our study demonstrated that prenatal exposure to
Cu NPs trigger a potent immune Th1/Th2 response in off-
spring that appear to be activating many pro-inflammatory
pathways. However, there was no strong skew either to Th1
or Th2 immune responses in either dams or offspring. We
conclude that the changes in expression of immune-
response genes in the pups with prenatal Cu NP exposure
are due to changes in inflammatory and immune responses
of mothers caused by inhalation of Cu NPs rather than due
to direct effect of NPs on fetus, since no translocation of
Cu was observed through the placenta to the fetus. Further
investigation focused on pulmonary prenatal exposure to
NPs with postnatal pathogen or allergen challenge, espe-
cially in early postnatal stages, might expand our under-




Cu NPs with a primary particle size reported by the manu-
facturer of 25 nm were purchased from Nanostructured
and Amorphous Materials, Inc. (Houston, TX, USA) and
used without any further intentional modification. The par-
ticles were characterized by X-ray diffraction (XRD) using a
Bruker D-5000 q – q X-ray diffractometer with a Kevex-
sensitive detector (Madison, WI). The primary size of the
Cu NPs was assessed by transmission electron microscopy
(TEM, JEOL JEM-1230, Japan) by sizing nearly 1500 parti-
cles. X-ray photoelectron spectroscopy (XPS) was used to
measure the surface chemical composition of the powdered
sample (Ultra-Axis XPS, Kratos, Manchester, UK). The
surface area was measured with an automated multipoint
Brunauer-Emmett-Teller (BET) surface area apparatus
using a nitrogen adsorption method (Quantachrome Nova
4200e, Boynton Beach, FL).
Animals
Mice (C57Bl/6 males and females, 6 wks old) were pur-
chased from Jackson Laboratories (Bar Harbor, ME). All
animals were housed in our AAALAC-accredited vivar-
ium, in polypropylene, fiber-covered cages in HEPA-
filtered Thoren caging units (Hazelton, PA). They were
acclimatized for 10 days after their arrival and were
maintained in the vivarium with a 12-hr light/dark cycle
with ad libitum access to food and water. All protocols
performed were approved by our Institutional Animal
Care and Use Committee. Animal handling and expo-
sures conformed to the NIH Guide for the Care and Use
of Laboratory Animals. Timed pregnancies were estab-
lished by mating 2 nulliparous females with one single
mature male for two days. Each morning the presence of
vaginal plug was assessed and if found, the event was
considered as gestation day (GD) 1.
Study experimental design
Pregnant (n = 9) and non-pregnant mice (n = 10) were
exposed to atmospheres of Cu NP-aerosol by inhalation for
4 hr/day in a dynamic whole-body exposure chamber from
GD 3 – to GD 19 (total of 17 days). The average mass con-
centration of nanoparticle-laden aerosol in the whole-body
chamber was 3.5 ± 1.2 mg/m3 (mean ± standard deviation).
Shams, (control mice) pregnant (n = 10) and non-pregnant
(n = 10) were exposed to HEPA-filtered laboratory air in
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the identical exposure chamber in an adjacent laboratory.
The schematic of the study experimental design with the
number of mice per each evaluated endpoint is shown in
Fig. 1. Pregnant and non-pregnant mice were euthanized
with an overdose of isoflurane followed by cervical disloca-
tion, thoracotomy and exsanguination through the heart.
One group of dams was euthanized on GD 19 and the pups
were delivered by C-section (0 wk post exposure). Another
group of mice delivered pups spontaneously on GD 18–20;
these pups were euthanized at 50 postnatal days (PND, 7
wks from delivery).
Generation of NPs and exposure system
The exposure as well as the generation system were
described previously [66]. Briefly, a dynamic whole-body
exposure chamber was used for animal exposure. Cu NP
aerosol was generated from suspension of Cu NPs in
water (Optima grade, Fisher Scientific, Pittsburgh, PA)
using a 6-jet Collison nebulizer (BGI Inc. Waltham,
MA). Suspensions of Cu NPs in water that were placed
into the nebulizer were prepared freshly each day by
ultra-sonication with a high frequency probe for 20 mi-
nutes. A magnetic stir bar was added into the nebulizer
to prevent settling the particles. Particle-laden aerosol
from the nebulizer passed through a brass drying col-
umn heated to 110 °C and particle neutralizer (contain-
ing 10 mCi 85Kr source, TSI Inc., Shoreview, MN) prior
to entering the chamber. Mass exposure concentration
of generated aerosol was estimated using a gravimetric
method. Pre-weighed fiberglass filters (47 mm in diam-
eter, Whatman, Middlesex, UK) held in a stainless steel
sampler were connected to the exhaust outlet from the
whole-body chamber and sampled every 2 hrs with a
flow of 24 L/min. Filters were pre- and post-weighed in
a dedicated climate-controlled room using a microbalance
(XP26, Mettler Toledo, Mettler-Toledo, Inc., Columbus,
OH).
Tissue dosimetry
Cu in the blood and lungs from non-pregnant mice and
dams immediately after delivery and 50 days later, and in
placentas and in pups delivered by C-section on GD 19
were determined using inductively coupled plasma-mass
spectrometry (ICP-MS, Perkin-Elmer ELAN DRC II,
Norwalk, CT). The method number ITB001A from CDC
Laboratory Procedure Manual adapted for digested tissue
and Cu was used for these analyses [67]. Whole blood was
collected via heart exsanguination into tubes containing
EDTA anticoagulant and stored at 4 °C until analyses.
Whole blood was then diluted 50 x using a diluent com-
posed of isopropanol (1 % v/v), tetramethyl ammonium
hydroxide (1 % v/v), Triton X-100 (0.5 % v/v) and ammo-
nium pyrolidine dithiocarbamate (0.1 % w/v) in deionized
water. Lung tissue (left lobe) and placentas were excised
and stored at −80 °C. All tissues were then dried using a
Speed Vac concentrator (Savant SPD111V, Thermo
Scientific, Waltham, MA). Intact carcasses of pups were
dried in the oven at 100 °C for 5 hrs. Dry tissues were then
weighed and digested in a HotBlock™ digestion system
(Environmental Express, Mt. Pleasant, SC) at 95-98 °C
using 0.25 mL of high purity concentrated nitric acid
(Fisher Optima® grade). After cooling to room temperature,
the samples were diluted to 5.0 mL using deionized water.
Determination of total Cu in the whole blood and digested
tissues was performed using an ICP-MS with high-purity
argon (99.99 %), a PFA-ST nebulizer (Elemental Scientific,
Omaha, NE) and a 0.50 mm i.d. capillary connected to a
cyclonic spray chamber. Sample data were acquired by
using 20 sweeps/reading, 1 reading/replicate, and a dwell
time of 50 ms. Argon nebulizer gas flow rate was opti-
mized daily from 0.5 to 0.9 L/min. Data were acquired in
counts per second (cps). The following isotopes were
selected: 63Cu and 65Cu. Analytical calibration standards
were prepared from a single-element stock solution con-
taining 1 g/L of Cu stock solution (SPEX, Metuchen, NJ).
For the whole blood measurements, the standards were
diluted as follows: 1, 5, 10, 20, 50, 100, 500, 1000, and
2000 μg/L in the same diluent as used for the whole blood.
For determination of Cu in tissues and whole bodies,
following standard concentrations were used: 1, 5, 50, 100,
500, and 1000 μg/L in 2 % nitric acid. The method detec-
tion limit for Cu was less than 1 μg/kg. Rhodium was
included in the diluents at 10 μg/L as an internal standard.
Estimated deposited dose
The estimated pulmonary deposited dose in this study
was 141 μg/mouse. We assumed a minute volume of
25 mL/min and a deposition fraction of 0.4 in tracheo-
bronchial and pulmonary region combined. Deposition
fraction for 36 nm particles was estimated based on the
computational modeling of regional deposition fraction
for mice reported by Asgharian et al. [68].
BAL fluid and plasma evaluation
To assess pulmonary inflammatory response, BAL was
performed in dams after C-section and 7 wks later and
in 7-wk-old pups. Lungs were washed 3 times with
about 1 mL of 0.9 % sterile sodium chloride solution
(Baxter, Deerfield, IL). BAL was centrifuged at 800 × g
for 5 min at 4 °C, supernatants were frozen at −80 °C for
later cytokines/chemokines analyses and cells were re-
suspended in Hank’s balanced salt solution (Life Tech-
nologies, Grand Island, NY). The total number of cells
was counted using a hemocytometer. The rest of the cell
suspension was fixed on microslides with fetal calf serum
(Cytospin 4, Thermo Shandon, Thermo Scientific, Wal-
tham, MA), and stained using Protocol® HEMA 3 stain set
(Fisher Diagnostics, Pittsburgh, PA). Differential cell
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counts (number of macrophages, neutrophils, lympho-
cytes, and eosinophils) were determined by counting 400
cells using an optical microscope (Olympus, Center Valley,
PA). Cytokines/chemokines in BAL fluid supernatants and
plasma of dams/non-pregnant mice and pups were ana-
lyzed using a multiplex magnetic bead assay (Luminex
100, Bio-Rad Laboratories, Inc., Hercules, CA).
Gene expression by RT-qPCR (reverse transcription
real-time quantitative polymerase chain reaction)
RNA Isolation
Lungs and spleens (~30 mg of each tissue) from exposed
and unexposed 7-wk-old pups were fixed in RNAlater
RNA stabilization reagent (SABiosciences, Qiagen, Val-
encia, CA, USA) and stored at −20 °C until RNA isola-
tion. Total RNA was extracted using the RNeasy Mini
Kit (Qiagen) after tissue homogenization in RLT buffer
with the addition of β-mercaptoethanol using a hand-
held homogenizer. Genomic DNA was removed utilizing
RNase-Free DNase Set (Qiagen). The quality and quan-
tity of a selected number of isolated RNAs were assessed
using the Experion automated electrophoresis system
(Bio-Rad Laboratories, Inc., Hercules, CA) and the
Experion RNA StdSens Analyses kit according to manu-
facturer’s instructions. The quality of the RNA was con-
sidered sufficient if the 28S/18S rRNA (ribosomal RNA)
ratio was between 1 and 2 and RNA Quality Indicator
(RQI) was > 8. All samples were also checked by the
NanoDrop spectrophotometer (Thermo Fisher Scientific,
Wilmington, DE); the OD260/OD280 ratio between 1.8–
2.0 was considered acceptable.
Isolated RNA (0.5 μg) was converted to cDNA using
the RT2 First strand kit and mixed with RT2 qPCR SYBR
Green mastermix (SABiosciences, Qiagen). Samples were
loaded onto a 96-well PCR array (Mouse Th1 & Th2
Responses RT2 Profiler PCR Array, PAMM-034ZA)
according to manufacturer’s instructions and read using a
CFX96 Touch Real-Time PCR Detection System (Bio-
Rad Laboratories, Inc., Hercules, CA). The thermocycling
conditions were 1 cycle of 95 °C for 10 min (HotStart
DNA Taq Polymerase activation) followed by 40 cycles of
95 °C for 15 s and 60 °C for 1 min (fluorescence data
collection). Melting curves were performed each time
from 55 °C to 95 °C with increments of 0.5 °C for 5 s to
ensure that only one amplification product was formed.
Histopathology
Lungs (right lobes) after BAL were perfused via the cannu-
lated trachea and fixed in 10 % zinc formalin (Fisher Scien-
tific, Kalamazoo, MI). Placentas of dams after C-section
delivery were harvested and also fixed in 10 % zinc forma-
lin. Tissues were then paraffin-embedded, sectioned (5-μm
thickness) and stained with hematoxylin and eosin (H&E).
All tissues were evaluated by a board-certified veterinary
pathologist for key histopathologic changes including but
not limited to inflammatory cell infiltration, fibrosis and
cellular injury and necrosis.
Statistical analyses
All data are expressed as mean ± standard error (SE) unless
otherwise noted. The data were analyzed using a T-test or
one-way analysis of variance (ANOVA) followed by a Tukey
test if treatment group sizes were equal. Dunn’s test was
used in cases when treatment group sizes were unequal. If
the Normality Test failed, Kruskal-Wallis one-way ANOVA
on Ranks was used. If the Equal Variance test failed, data
were analyzed using the Mann–Whitney Rank Sum Test
(Sigma Plot v.11.0, Systat Software Inc., Point Richmond,
CA). The LIFETEST procedure and Wilcoxon Chi-square
test were used to compare survival rates of exposed and
control pups. The GLM procedure was used to assess
differences in weight gain in dams and pups (SAS software
Version 9.4, SAS Institute Inc., Cary, NC). The 84 genes
that were assessed in the array related to Th1 and Th2
responses were analyzed using the RT2 Profiler PCR Array
data Analysis software version 3.5 (http://pcrdataanalysis.
sabiosciences.com/pcr/arrayanalysis.php, SABiosciences,
Qiagen). A global mean approach was used for normalization
of all samples. A p-value less than 0.05 was considered
statistically significant.
Additional file
Additional file 1: Placenta histopathology. Representative micrographs of
placenta sections stained with H&E from mice exposed prenatally to Cu NPs
or laboratory air (shams). No significant pathological changes were found in
the placentas from exposed animals compared to the controls. Bars = 200 μm
(inset, bars = 20 μm). A = labyrinth layer, B = spongiotrophoblast layer,
C = decidual layer. (PDF 322 kb)
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